Carbonic anhydrase IX (CAIX) and cysteine desulfurase (NFS1) are a synthetic lethal pair for cancer treatment. The suppression of NFS1 upregulates the iron starvation response and enriches intracellular Fe2+, leading to increased lipid peroxidation. However, the potency of the NFS1 inhibitor is compromised by the hypoxic microenvironment. To address this issue, we report a mechano-responsive ferrocene-bearing micelle that mimics the CAIX/NFS1 axis via ultrasound-activated iron release and the co-delivery of SLC-0111, a CAIX inhibitor. Upon ultrasound stimulation, the micelles disassemble in acidic lysosomes, releasing ferrous ions and SLC-0111, triggering intracellular acidification, reactive oxygen species accumulation, and lipid peroxidation. Moreover, the liberation of Fe2+ is facilitated by the presence of hydrogen peroxide and further enhanced by mechanical force. SLC-0111 leads to intracellular acidification and synergizes with Fe2+ to boost the Fenton reaction. This cascade disrupted redox homeostasis and induced multiple cell death pathways, including ferroptosis, apoptosis, pyroptosis, and necroptosis, in a tumor-selective manner. The in vivo efficacy studies in a 4T1 breast cancer model confirmed potent tumor suppression with minimal systemic toxicity. This work introduces a mechanical force-controlled strategy as a substitute for CAIX/NFS1 synthetic lethality therapy without the interference of oxygen level, holding promise for advancing tumor-specific therapy.